Mawer Investment Management LTD Has Lifted Stake in Novartis Ag (NVS)

April 20, 2018 - By Clifton Ray

Novartis AG (NYSE:NVS) Logo

Mawer Investment Management Ltd increased its stake in Novartis Ag (NVS) by 3.49% based on its latest 2017Q4 regulatory filing with the SEC. Mawer Investment Management Ltd bought 92,908 shares as the company’s stock declined 4.22% with the market. The institutional investor held 2.76M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $231.58M, up from 2.67M at the end of the previous reported quarter. Mawer Investment Management Ltd who had been investing in Novartis Ag for a number of months, seems to be bullish on the $182.57B market cap company. The stock decreased 1.54% or $1.22 during the last trading session, reaching $77.78. About 2.62M shares traded or 38.49% up from the average. Novartis AG (NYSE:NVS) has risen 5.79% since April 20, 2017 and is uptrending. It has underperformed by 5.76% the S&P500.

Mawer Investment Management Ltd, which manages about $20.93B and $12.09 billion US Long portfolio, decreased its stake in Becton Dickinson And Co (NYSE:BDX) by 97,258 shares to 1.70 million shares, valued at $365.19 million in 2017Q4, according to the filing. It also reduced its holding in Gazit Globe Ltd (NYSE:GZT) by 8.26M shares in the quarter, leaving it with 287,983 shares, and cut its stake in Autozone Inc (NYSE:AZO).

Novartis AG (NYSE:NVS) Ratings Coverage

Among 4 analysts covering Novartis AG Common Stock (NYSE:NVS), 0 have Buy rating, 2 Sell and 2 Hold. Therefore 0 are positive. Novartis AG Common Stock had 5 analyst reports since October 23, 2017 according to SRatingsIntel. Cowen & Co maintained the shares of NVS in report on Friday, February 2 with “Hold” rating. The rating was downgraded by Barclays Capital to “Sell” on Wednesday, October 25. Bank of America downgraded the shares of NVS in report on Wednesday, December 6 to “Sell” rating. The stock has “Market Perform” rating by Leerink Swann on Monday, October 23. The stock of Novartis AG (NYSE:NVS) has “Market Perform” rating given on Thursday, January 25 by Leerink Swann.

Novartis AG (NYSE:NVS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.